PLIANT THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
PLIANT THERAPEUTICS, INC. (PLRX) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2022-03-01
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2021-12-31 was $0.00.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2021-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2020-12-31 was $0.00.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2020-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2020 was $10.00M.
- PLIANT THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $10.00M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $10.00M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $10.00M 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |